• COVID-19
• Research dataclose
• Other research productsclose
• Open Access close
• Lecture close
• English close
• COVID-19 close

ispartof: pages:S305-S306 ispartof: SAFETY AND HEALTH AT WORK vol:13 pages:S305-S306 status: published

Abstract accepted for presentation at the annual BELMAS conference. Whilst the abstract will be accessible in the Conference's programme book, it will not be presented due to COVID-19 measures and the corresponding cancelation of the 2020 conference. ispartof: BELMAS 2020 location:De Vere Horwood Estate, Milton Keynes, UK date:3 Jul - 5 Jul 2020 status: published

The talk was given in the Best Paper Candidate session at 11:30am CET on the 24th of March 2021 at the 19th IEEE International Conference on Pervasive Computing and Communications (PerCom 2021) in Kassel, Germany. This version of the talk was pre-recorded as a backup by the author. The teaser summarized the paper in one minute and has been circulated on Twitter before the conference and is stored here for reference. The paper and talk introduces the concept of a Dense Indoor Sensor Network (DISN) and investigates whether Long Range Wide Area Networks (LoRaWAN) are a feasible technology to underpin a DISN. We test a DISN with 390 sensor devices in an office building at ETH Zürich for 5 months in 2020 - however, the system is still collecting data until at least December 2021. We find that the a gateway every 30m and 5 floors provides an effective coverage for a DISN based on LoRaWAN ensuring both signal quality and redundancy. The paper and talk also aim towards passively sense human presence based on a DISN. They give a preview of the collected data by using the COVID-19 induced lockdown as a natural experiment to expose the human-activity related variation in sensor measurements in the building.

In recent times, the transportation sector has experienced technological disruptions from the rapid developments in vehicle automation to the meteoric rise of ridesharing and ridehailing apps around the world. There is enormous uncertainty surrounding how these technological disruptions will play out in the long term. This uncertainty has been compounded by one of the most disruptive event in recent times, the COVID-19 pandemic, which has impacted all areas of urban life, including the transportation sector, at an unprecedented scale. Although we cannot predict the impacts of these disruptions (technological and otherwise) in the long term on cities, urban design and planning can play a strong role in steering their impacts. In this webinar, Tanvi Maheshwari, Prof. Stephen Marshall and Prof. Kay W. Axhausen discussed what these technological developments in transportation sector mean for urban design and planning in future cities. The topic Urban Design and the Technological Shift in Transportation arose from the PhD thesis of Tanvi Maheshwari, who recently completed her PhD in the Engaging Mobility project at the Future Cities Laboratory (FCL). The panel discussion was chaired by Prof. Stephen Cairns, director of the FCL.

Throughout the evolution of the global COVID-19 pandemic, much of the public attention has been turned towards timely delivery of vaccine doses, to the attached verbal and contractual arm-wrestling between governments and pharmaceutical companies, or yet to the debate on the feasibility of a waiver on related IP rights. However, another exchange of uttermost importance has been left somewhere out of the limelight: pathogen sharing. As a matter of fact, sharing among laboratories of SARS-CoV-2 causing COVID-19 has been the first link within the chain of development of diagnostics, vaccines, and therapeutics. Despite its relevance in upstream research, pathogen sharing has been taken for granted in the backstage of “science happening”, this perhaps stemming from the understanding that pathogens fall within the category of “commons”. However, a strict reading of the (CBD) (1992) and the Nagoya Protocol to such Convention (NP) (2014) ̶ legal instruments seeking to counter the misappropriation of genetic resources of countries and associated traditional knowledge ̶ leads to pathogens generally falling under the umbrella of “genetic resources”. As such, they pertain to the country of origin, which must “consent” to these being accessed on “mutually agreed terms” covering “access and benefit sharing” (ABS) arrangements to benefits issued from such utilization. In past epidemics ̶ H5N1 (2006), MERS-COV (2012)̶ Indonesia and Saudi Arabia instrumentalized and reframed CBD language to “legally” restrict access to such pathogens, in a narrative move qualified as viral sovereignty. If the outbreak in China was not accompanied by any such sovereign claims, a recent WHO Report on “The public health implications of the implementation of the Nagoya Protocol” (6/Jan/2021) underlined NP effects during the COVID-19 pandemic. The aim of this session is to discuss such implications, namely the NP acting like a double-edged sword: creating suitable frameworks for SARS-CoV-2 sharing but also considerable brakes; followed by a discussion on the operationalization of Article 8b NP (expeditious access to genetic resources in health emergencies). ispartof: Global Congress of Intellectual Property and the Public Interest location:Cartagena, Colombia (online) date:25 Oct - 29 Oct 2021 status: Published online

Medical museums can play a major role in society by contributing to health and wellbeing. There are over 240 museums displaying historical medical collections in Europe, and more than 37 million visitors have attended anatomical exhibitions such as Gunther von Hagens’ Body Worlds. Clearly there is great public interest in these presentations of health and medicine, although there is also much disagreement about what should be shown, who should see it, and what audiences might gain from such encounters with the past. This presentation will demonstrate the importance of medical heritage for understanding history, but also in addressing contemporary public health problems, from the stigma of illness or disability, issues of sexuality and reproduction, or the challenges of the COVID-19 pandemic. Innovative uses of sounds, objects, images, and exhibitions will be examined to show how classrooms as well as cultural venues are introducing diverse groups to the material culture of the history of medicine, to promote health, as well as learning. The conclusion highlights the role of the VU MA in Medical and Health Humanities in this work, and the relevance of history and historical collections for engaging health professionals as well as broader audiences.